Harvard Apparatus up 15% premarket

Regenerative medicine firm Harvard Apparatus Regenerative Technology (HART) is poised for a strong open this morning.

The firm split off from Harvard Bioscience (HBIO) in November.

No specific news released.

The firm will report its financial results before the open on March 7.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs